_version_ 1785131622053445632
author Crusoe, Edvan de Queiroz
Hallack Neto, Abrahão Elias
Nantes, Deise Ferreira
Ribeiro, Eduardo Flavio Oliveira
Pinto, Fernando Monteiro Correia
Bortolini, Jaisson Andre Pagnoncelli
Maciel, James Farley Rafael
Marques Junior, Jose Francisco Comenalli
Corrêa, Lorena Costa
Capra, Marcelo Eduardo Zanella
Carvalho, Maria do Perpétuo Socorro Sampaio
de Melo, Nelcivone Soares
Quintas, Rafaela Vasques de Oliveira
Carneiro, Thiago Xavier
Laforga, Violete Petitto
Cunha, Renato Luiz Guerino
author_facet Crusoe, Edvan de Queiroz
Hallack Neto, Abrahão Elias
Nantes, Deise Ferreira
Ribeiro, Eduardo Flavio Oliveira
Pinto, Fernando Monteiro Correia
Bortolini, Jaisson Andre Pagnoncelli
Maciel, James Farley Rafael
Marques Junior, Jose Francisco Comenalli
Corrêa, Lorena Costa
Capra, Marcelo Eduardo Zanella
Carvalho, Maria do Perpétuo Socorro Sampaio
de Melo, Nelcivone Soares
Quintas, Rafaela Vasques de Oliveira
Carneiro, Thiago Xavier
Laforga, Violete Petitto
Cunha, Renato Luiz Guerino
author_sort Crusoe, Edvan de Queiroz
collection PubMed
description
format Online
Article
Text
id pubmed-10627862
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-106278622023-11-08 Equity program: strategies on clinical studies as an aggregating potential Crusoe, Edvan de Queiroz Hallack Neto, Abrahão Elias Nantes, Deise Ferreira Ribeiro, Eduardo Flavio Oliveira Pinto, Fernando Monteiro Correia Bortolini, Jaisson Andre Pagnoncelli Maciel, James Farley Rafael Marques Junior, Jose Francisco Comenalli Corrêa, Lorena Costa Capra, Marcelo Eduardo Zanella Carvalho, Maria do Perpétuo Socorro Sampaio de Melo, Nelcivone Soares Quintas, Rafaela Vasques de Oliveira Carneiro, Thiago Xavier Laforga, Violete Petitto Cunha, Renato Luiz Guerino Hematol Transfus Cell Ther Editorial Sociedade Brasileira de Hematologia e Hemoterapia 2023 2023-07-13 /pmc/articles/PMC10627862/ /pubmed/37500357 http://dx.doi.org/10.1016/j.htct.2023.07.001 Text en © 2023 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Crusoe, Edvan de Queiroz
Hallack Neto, Abrahão Elias
Nantes, Deise Ferreira
Ribeiro, Eduardo Flavio Oliveira
Pinto, Fernando Monteiro Correia
Bortolini, Jaisson Andre Pagnoncelli
Maciel, James Farley Rafael
Marques Junior, Jose Francisco Comenalli
Corrêa, Lorena Costa
Capra, Marcelo Eduardo Zanella
Carvalho, Maria do Perpétuo Socorro Sampaio
de Melo, Nelcivone Soares
Quintas, Rafaela Vasques de Oliveira
Carneiro, Thiago Xavier
Laforga, Violete Petitto
Cunha, Renato Luiz Guerino
Equity program: strategies on clinical studies as an aggregating potential
title Equity program: strategies on clinical studies as an aggregating potential
title_full Equity program: strategies on clinical studies as an aggregating potential
title_fullStr Equity program: strategies on clinical studies as an aggregating potential
title_full_unstemmed Equity program: strategies on clinical studies as an aggregating potential
title_short Equity program: strategies on clinical studies as an aggregating potential
title_sort equity program: strategies on clinical studies as an aggregating potential
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627862/
https://www.ncbi.nlm.nih.gov/pubmed/37500357
http://dx.doi.org/10.1016/j.htct.2023.07.001
work_keys_str_mv AT crusoeedvandequeiroz equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT hallacknetoabrahaoelias equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT nantesdeiseferreira equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT ribeiroeduardoflaviooliveira equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT pintofernandomonteirocorreia equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT bortolinijaissonandrepagnoncelli equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT macieljamesfarleyrafael equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT marquesjuniorjosefranciscocomenalli equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT correalorenacosta equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT capramarceloeduardozanella equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT carvalhomariadoperpetuosocorrosampaio equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT demelonelcivonesoares equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT quintasrafaelavasquesdeoliveira equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT carneirothiagoxavier equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT laforgavioletepetitto equityprogramstrategiesonclinicalstudiesasanaggregatingpotential
AT cunharenatoluizguerino equityprogramstrategiesonclinicalstudiesasanaggregatingpotential